Compuestos policíclicos

(+)(1S,2S,4R)-Bicyclo[2.2.1]heptane-2-amine is a heterocyclic compound that contains a nitrogen atom and an amine group. It has been shown to be a potent inhibitor of the enzyme activities of malonic acid decarboxylase and acetylcholinesterase. This compound can be used as a diagnostic tool for chronic kidney disease, specifically in cases of renal failure and polycystic kidney disease. The palladium complexes can be used for the synthesis of (+)(1S,2S,4R)-bicyclo[2.2.1]heptane-2-amine in high yield from malonic acid and ammonia.

2-Acetamido-6-chloropurine (2ACAP) is a nucleophilic agent that inhibits cancer cells by binding to the enzyme cholinesterase. It is used in the treatment of T-cell leukemia and herpes simplex virus. 2ACAP binds to the amine group of cholinesterase, which prevents it from breaking down acetylcholine. This inhibition leads to accumulation of acetylcholine, which has been shown to induce apoptosis in k562 cells. The molecular modeling study showed that 2ACAP binds to both chlorine atom and benzyl groups in the active site of cholinesterase. 2ACAP also has a potent inhibitory effect on cancer cell proliferation and can be used as an anti-cancer agent for many types of cancers including colon, breast, and prostate cancer.

Quinolin-4-ylboronic acid is a heterocyclic compound with two nitrogen atoms that are attached to the ring by means of carbonyl groups. This compound is a precursor in the synthesis of the drug dorsomorphin, which is used for pain relief. It also has an important role in pharmacokinetics because it can be used as a marker for estimating blood levels of other drugs. Quinolin-4-ylboronic acid yields an active form, quinolin-4-yl boronic acid, when reacted with piperazine in basic conditions. The drug ldn-193189 is a derivative of this active form and has been evaluated as a potential drug for treating osteoporosis and cancer.

5-Bromoisatoic anhydride is a potential anticancer agent that contains nitrogen atoms. It inhibits the growth of cancer cells by binding to the enzyme acetylcholine, which is involved in the production of growth factors. The compound also inhibits the production of malonic acid, which is a metabolic disorder. 5-Bromoisatoic anhydride forms stable complexes with malonic acid and does not cause any adverse effects on normal cells.

Meranzin is a bioactive compound, which is a naturally occurring coumarin derivative found in various citrus fruits. Its source lies primarily in the peels and seeds of specific citrus species, notably within the Rutaceae family. The mode of action of Meranzin involves the inhibition of acetylcholinesterase, thereby influencing neurotransmitter activity, specifically in the modulation of acetylcholine levels. This action can have significant implications in research focused on neurodegenerative disorders.

1,10-Phenanthroline-2-carbaldehyde is a phenylhydrazone compound that has been shown to have anticancer activity. It is also a supramolecular complex, which means it can form hydrogen bonds and coordinate bonds with other molecules. The anticancer activity of 1,10-phenanthroline-2-carbaldehyde may be due to its ability to inhibit the growth of prostate carcinoma cells. This compound also inhibits the growth of human cervical carcinoma cells by binding to their DNA and inhibiting the synthesis of RNA and protein. 1,10-Phenanthroline-2-carbaldehyde is being studied for its potential as an inhibitor of tumor angiogenesis.
1,10-Phenanthroline-2-carbaldehyde has been shown to have antiplatelet aggregation effects in platelets from healthy humans as well as those with type 2 diabetes mellitus or chronic kidney disease.

5,6-Methylenedioxyindole (MDI) is a compound that is often used in the synthesis of other bioactive molecules. It has been shown to bind to the pyridinium moiety of receptor sites and form a stable complex, which can then be displaced by an agonist or antagonist. The binding experiments were performed using radioactive MDI and zoxazolamine as the ligand. Radiolabelled MDI was synthesized from 5-methyl-2-pyridinone with the use of a linker, methylenetriphenylphosphorane (MTPP). The molecular electrostatic potentials of the two compounds were calculated in order to investigate the possible binding interactions between them. Ellipticines are also synthesised using MDI as a precursor molecule, which is alkylated with dimethyl sulfate and then reacted with phenylhydrazine. This reaction produces a mixture containing both ellipticines and

1-Phenanthrol is a naturally occurring phenanthrene derivative that is used in the treatment of cervical cancer. It has been shown to be effective in the chemiluminescence method using urine samples, which indicates that it may have an effect on the body's metabolism. 1-Phenanthrol has also been shown to inhibit the production of s-phenylmercapturic acid, which is a metabolite of aromatic amines. This inhibition may be due to its receptor binding properties as it binds to and activates the peroxisome proliferator-activated receptor alpha (PPARα) and PPARγ. 1-Phenanthrol also inhibits angiotensin II type 1 receptors and can cause vasorelaxation by reducing blood pressure.

6-Methylpurine is a product of the nucleotide metabolism in E. coli, which is a model organism for protein synthesis. 6-Methylpurine inhibits protein synthesis and exerts significant cytotoxicity. It has been shown to inhibit the enzyme activities of DNA polymerase alpha, DNA ligase, and RNA polymerase, as well as other enzymes involved in nitrogen metabolism. 6-Methylpurine has been shown to be an analog of adenine and has a similar reaction mechanism. The uptake of 6-methyl purine by cells is mediated by hydrogen bonds with amino acid residues on the cell membrane surface. This molecule also forms glycosidic bonds with ribose sugar groups on cellular surfaces. 6-Methylpurine plays an important role in energy metabolism through its incorporation into glucose and glycogen molecules.

Please enquire for more information about 4,5-Dicyanoimidazole including the price, delivery time and more detailed product information at the technical inquiry form on this page

7-Hydroxyindole is a biochemical that is produced by wild-type strains of Escherichia coli. It has been shown to inhibit the action of an efflux pump, which is a protein that pumps drugs and other foreign substances out of the cell. The alkoxy radical reacts with 7-hydroxyindole to form a hydroperoxide intermediate. This intermediate then reacts with molecular oxygen to form hydrogen peroxide, which may be responsible for the antimicrobial activity of 7-hydoxyindole. Studies have shown that this compound can also inhibit multidrug efflux pumps in Pseudomonas aeruginosa cells, which may lead to an increase in antibiotic uptake.

6-Chloro-7-iodo-7-deazapurine is a nucleoside analogue that is synthesized by a cross-coupling reaction between 6-chloro-2,4(1H,3H)-pyrimidinedione and 7-iodo-7-(trifluoromethyl)purine. 6CIDP has been shown to inhibit growth of epidermal cells at concentrations as low as 0.1 µM, with cytostatic effects seen at 10 µM. 6CIDP has also been shown to potently inhibit the replication of the human papilloma virus in vitro and in vivo. 6CIDP is currently being investigated for the treatment of AIDS and other viral infections. The molecular modeling studies on this compound have revealed that it may be a potent inhibitor of the epidermal growth factor receptor (EGFR).

7-Chloro-2H-pyrido[3,2-B]-1,4-oxazin-3(4H)-one is a chemical which is used as a reagent and building block in the synthesis of more complex compounds. It has been reported to be an intermediate for the production of pharmaceuticals and agrochemicals. The compound can also be used as an intermediate for the synthesis of other valuable chemicals such as pesticides and dyes. 7-Chloro-2H-pyrido[3,2-B]-1,4-oxazin-3(4H)-one has a CAS number of 205748-05-6.